Digipath Inc (OP: DIGP )

0.0104 UNCHANGED

Last Price Updated: 3:59 PM EDT, Aug 12, 2024 Add to My Watchlist

Price and Volume

Volume	0
Open	0.0104
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0104
Today's Range	0.0104 - 0.0104
52wk Range	0.0073 - 0.0700
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Hypha Labs' Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily Press

July 31, 2024

Via ACCESSWIRE

CORRECTION: Hypha Laboratories Retains Integrity Media for Investor Relations and Corporate Communications

July 19, 2024

Via ACCESSWIRE

Performance

YTD	-73.33%	-73.33%
1 Month	N/A	N/A
3 Month	-28.28%	-28.28%
6 Month	-68.77%	-68.77%
1 Year	-35.00%	-35.00%

More News

CORRECTION: Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence (A.I.) Driven In-Home Mycelium Production

July 19, 2024

Via ACCESSWIRE

Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence (A.I.) Driven In-Home Mycelium Production

June 24, 2024

Via ACCESSWIRE

Hypha Laboratories Retains Integrity Media for Investor Relations and Corporate Communications

June 11, 2024

Via ACCESSWIRE

Hypha Labs Announces New Patent Filing

May 20, 2024

Via ACCESSWIRE

Hypha Labs Names Craig Ellins Chief Science Officer

April 29, 2024

Via ACCESSWIRE

Digipath Announces Results for the Fiscal Year 2021

January 04, 2022

Via NewMediaWire

Digipath Enters Psilocybin Industry and Changes Name

April 22, 2024

Via ACCESSWIRE

Hypha Labs, Inc. to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

April 18, 2024

Via ACCESSWIRE

Digipath Announces Record Earnings of $292,533 for Recent Quarter Ended June 30

August 29, 2023

Via NewMediaWire

Digipath, Inc. Signs Agreement to Sell the Assets of Its Lab Subsidiary

May 05, 2023

Via NewMediaWire

Digipath, Inc. Announces Revenue Increase of Almost 18% for the Fourth Quarter of Fiscal Year 2022

December 08, 2022

Via NewMediaWire

Digipath Validates and Receives Approval to Use Free DNA Removal to Test for Aspergillus

May 02, 2022

Via NewMediaWire

Digipath To Test Redwood Cultivation Products, Including Mike Tyson's Ear Shaped Cannabis Gummies

April 04, 2022

Via Benzinga

Digipath to Provide Product Testing for Redwood Cultivation Products, Including Mike Tyson's New Ear Shaped Gummies, 'Mike Bites'

April 04, 2022

Via NewMediaWire

Digipath Teams Up With CASPR Technologies To Determine Efficacy For New Anti-Microbial Product For Cannabis Industry

March 01, 2022

Via Benzinga

Digipath Enters into Validation Agreement with CASPR Technologies to Determine Efficacy for New Anti-Microbial Product for the Cannabis Industry

March 01, 2022

Via NewMediaWire

Digipath Reports Substantial Sequential Growth In Gross Profit & Revenue In Q1

February 15, 2022

Via Benzinga

Digipath Announces Financial Results for Q1, 2022

February 15, 2022

Via NewMediaWire

Digipath Obtains Coveted Compliance Testing License for California Laboratory

February 09, 2022

Via NewMediaWire

Digipath Takes Over Management & Signs Letter of Intent to Acquire Majority Control of Steep Hill's Licensed Northern California Lab from Evio Labs

December 07, 2021

Via NewMediaWire

Digipath, Inc. to Present at the Emerging Growth Conference on Wednesday, December 8th at 12n EST/ 9:00 am PST

December 06, 2021

Via NewMediaWire

Digipath Announces Results for Third Fiscal Quarter 2021

August 18, 2021

Via NewMediaWire

Cannabis Movers & Shakers: Nevada CCB, Digipath, Agricor And Botanacor Laboratories, Curaleaf, Hervé, HERBL

July 14, 2021

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.